United States v. Kai-Lo Hsu, A/K/A James Hsu. United States of America v. Chester S. Ho. United States of America

155 F.3d 189, 47 U.S.P.Q. 2d (BNA) 1784, 1998 U.S. App. LEXIS 20810, 1998 WL 538221
CourtCourt of Appeals for the Third Circuit
DecidedAugust 26, 1998
Docket97-1965
StatusPublished
Cited by82 cases

This text of 155 F.3d 189 (United States v. Kai-Lo Hsu, A/K/A James Hsu. United States of America v. Chester S. Ho. United States of America) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Kai-Lo Hsu, A/K/A James Hsu. United States of America v. Chester S. Ho. United States of America, 155 F.3d 189, 47 U.S.P.Q. 2d (BNA) 1784, 1998 U.S. App. LEXIS 20810, 1998 WL 538221 (3d Cir. 1998).

Opinion

OPINION OF THE COURT

RENDELL, Circuit Judge:

In this appeal we explore for the first time the relationship between the confidentiality provisions of the newly-enacted Economic Espionage Act of 1996, 18 U.S.C. § 1831, et seq., and principles of criminal law regarding discovery and disclosure of material evidence. The district court ordered the government to disclose alleged corporate trade secrets based upon a theory that we find does not apply. It also held that the defense of legal impossibility does not pertain to the attempt and conspiracy crimes with which the defendants are charged. We will affirm the court’s holding regarding the applicability of the defense of legal impossibility, but will reverse its discovery order and remand for a review of other asserted defenses to the crimes in the indictment.

I. FACTUAL AND PROCEDURAL BACKGROUND

A. The Government’s Sting Operation

On July 10, 1997, a federal grand jury indicted Kai-Lo Hsu, Chester S. Ho, and Jessica Chou (collectively, “the defendants”) for their involvement in an alleged conspiracy to steal corporate trade secrets from Bristol-Myers Squibb. The indictment alleges that the defendants sought to obtain the *192 processes, methods, and formulas for manufacturing Taxol, an anti-cancer drug produced by Bristol-Myers and regarded by the company as a highly valuable trade secret. 1

According to the indictment, the defendants’ conspiracy began on June 7, 1995, when Chou, the Manager of Business Development for Yuen Foong Paper Company in Taiwan (“YFP”), requested information about Taxol from John Hartmann, an undercover FBI agent whom Chou mistakenly believed to be a technological information broker in the United States. From August 28, 1995, until January 12, 1996, Chou allegedly contacted Hartmann repeatedly to obtain information about Taxol manufacturing techniques and distribution. These contacts led to a meeting in Los Angeles on February 27, 1996, between Hartmann and Hsu, the Technical Director for YFP’s operations. Hsu purportedly told Hartmann at that meeting that YFP wanted to diversify into biotechnology and to introduce technology from advanced countries into Taiwan. When Hart-mann responded that Bristol-Myers would be unlikely to share its secret technology with YFP, Hsu allegedly responded, “We’ll get [it] another way,” and told Hartmann to pursue paying Bristol-Myers employees for the confidential Taxol formulas.

The indictment asserts that Hsu and Chou then “communicated many times” with Hart-mann over the next fourteen months to discuss the transfer of Taxol technology and to negotiate a specific price for the acquisition of Bristol-Myers’s trade secrets. In response, Hartmann told the defendants that a corrupt Bristol-Myers scientist would be willing to sell Taxol information to YFP. The “corrupt” scientist was actually a Bristol-Myers employee cooperating with the FBI. Intrigued by such a prospect, Chou allegedly sent an e-mail to Hartmann on March 13, 1997, outlining the “core technology” that YFP would need to complete a deal, including:

“1. The design and assembly of bioreactor with an agreed scale
2.. Light requirement
3. Media requirement for growth and production
4. Operating mode for the process, such as batch or continuous
5. Yield, such as cell density, titers, taxane constitution
6. Duration of culture to reach the maximal yield
7. Scientific names of yew species which are applicable to the bioreactor.
8. Cell lines excluded!!!”

Chou also allegedly told Hartmann that she would offer $400,000 in cash, stock, and royalties to the Bristol-Myers scientist in exchange for his disclosure of the Taxol secrets. In addition, Chou and Hsu purportedly began making arrangements for a 1997 meeting between the parties, the purpose of which was for YFP to establish the authenticity of the “corrupt” scientist and to determine whether Hartmann really could produce the Taxol trade secrets that Chou and Hsu had requested.

Hartmann agreed to a meeting, and on June 14, 1997, he and the Bristol-Myers scientist met with three representatives from YFP, including Hsu, Ho, and another unidentified scientist, at the Four Seasons Hotel in Philadelphia. Ho was a professor of biotechnology and the Director of the Biotechnology Innovation Center at the National Chiao Tung University in Taiwan, and he had apparently been asked to evaluate the Taxol technology at the meeting as a favor to YFP.

The indictment alleges that the bulk of the June 14 meeting consisted of detailed discussions regarding the manufacturing processes for Taxol. The Bristol-Myers scientist explained the background and history of Taxol production, and displayed copies of Bristol-Myers documents outlining specific technological processes and scientific data pertaining to the manufacture of the drug. According to the indictment, these doeu- *193 merits contained trade secrets and were “clearly marked with Bristol-Myers identification as well as the block stamped word ‘CONFIDENTIAL.’ ” Hsu, Ho, and the other YFP employee reviewed the documents during the meeting and purportedly asked the Bristol-Myers scientist “numerous” questions regarding specific areas of Taxol technology. Finally, after Hartmann and the Bristol-Myers scientist left the room, the FBI rushed in and arrested Hsu and Ho at the hotel. 2

The indictment returned by the grand jury charged Hsu, Ho, and Chou with six counts of wire fraud in violation of 18 U.S.C. § 1343, one count of general federal conspiracy in violation of 18 U.S.C. § 371, two counts of foreign and interstate travel to facilitate commercial bribery in violation of 18 U.S.C. § 1952(a)(3), one count of aiding and abetting in violation of 18 U.S.C. § 2, ánd, most importantly for our purposes, two counts of criminal activity under the Economic Espionage Act of 1996 (“the EEA”), including attempted theft of trade secrets, and a conspiracy to steal trade secrets, in violation of 18 U.S.C. §§ 1832(a)(4) and (a)(5).

B. The Government’s Motion to Maintain the Confidentiality of the Bristol-Myers Trade Secrets

Shortly after the indictment was returned, the defense requested in discovery a copy of the Bristol-Myers documents disclosed to Hsu and Ho at the June 14 meeting. However, on August 12, 1997, the government filed a motion pursuant to 18 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Ronald Vines
134 F.4th 730 (Third Circuit, 2025)
PEEK v. United States
D. New Jersey, 2024
United States v. Haitao Xiang
67 F.4th 895 (Eighth Circuit, 2023)
LIU v. United States
D. New Jersey, 2021
United States v. Shan Shi
991 F.3d 198 (D.C. Circuit, 2021)
United States v. Safehouse
985 F.3d 225 (Third Circuit, 2021)
United States v. Conigliaro
384 F. Supp. 3d 145 (District of Columbia, 2019)
United States v. James Garner
915 F.3d 167 (Third Circuit, 2019)
United States v. Christopher Lee
701 F. App'x 175 (Third Circuit, 2017)
United States v. Walter Liew
856 F.3d 585 (Ninth Circuit, 2017)
United States v. David Nosal
828 F.3d 865 (Ninth Circuit, 2016)
United States v. Nosal
844 F.3d 1024 (Ninth Circuit, 2016)
United States v. Ronald Salahuddin
765 F.3d 329 (Third Circuit, 2014)
United States v. Yijia Zhang
995 F. Supp. 2d 340 (E.D. Pennsylvania, 2014)
United States v. Martinez-Maldonado
722 F.3d 1 (First Circuit, 2013)
United States v. Wen Chyu Liu
716 F.3d 159 (Fifth Circuit, 2013)
United States v. Zhen Zhou Wu
711 F.3d 1 (First Circuit, 2013)
United States v. Hanjuan Jin
833 F. Supp. 2d 977 (N.D. Illinois, 2012)
State v. Adamcik
272 P.3d 417 (Idaho Supreme Court, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
155 F.3d 189, 47 U.S.P.Q. 2d (BNA) 1784, 1998 U.S. App. LEXIS 20810, 1998 WL 538221, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-kai-lo-hsu-aka-james-hsu-united-states-of-america-v-ca3-1998.